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Abstract
Background: Urethral reconstruction is one of the great surgical challenges for urologists. A cell-based tissue-
engineered urethra may be an alternative for patients who have complicated long strictures and need urethral
reconstruction. Here, we demonstrated the feasibility of using autologous urine-derived stem cells (USCs) seeded
on small intestinal submucosa (SIS) to repair a urethral defect in a rabbit model.
Methods: Autologous USCs were obtained and characterized, and their capacity to differentiate into urothelial
cells (UCs) and smooth muscle cells (SMCs) was tested. Then, USCs were labeled with PKH67, seeded on SIS, and
transplanted to repair a urethral defect. The urethral defect model was surgically established in New Zealand
white male rabbits. A ventral urethral gap was created, and the urethral mucosa was completely removed, with a
mean rabbit penile urethra length of 2 cm. The urethral mucosal defect was repaired with a SIS scaffold (control
group: SIS with no USCs; experimental group: autologous USC-seeded SIS; n = 12 for each group). A series of
tests, including a retrograde urethrogram, histological analysis, and immunofluorescence, was undertaken 2, 3, 4,
and 12 weeks after the operation to evaluate the effect of the autologous USCs on urethral reconstruction.
Results: Autologous USCs could be easily collected and induced to differentiate into UCs and SMCs. In addition,
the urethral caliber, speed of urothelial regeneration, content of smooth muscle, and vessel density were significantly
improved in the group with autologous USC-seeded SIS. Moreover, inflammatory cell infiltration and fibrosis were
found in the control group with only SIS, but not in the experimental autologous USC-seeded SIS group. Furthermore,
immunofluorescence staining demonstrated that the transplanted USCs differentiated into UCs and SMCs in vivo.
Conclusions: Autologous USCs can be used as an alternative cell source for cell-based tissue engineering for
urethral reconstruction.
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Background
Reconstruction of the adult and pediatric male penile
urethra has been one of the great surgical challenges
for urologists, especially in cases of recurrent hypospa-
dias and long urethral defects after trauma. More than
200 different reconstructive methods for urethral stric-
ture disease or congenital absence have been described,
with a variety of donor tissues, such as free skin grafts
[1], bladder mucosa [2], buccal mucosa [3], and lingual
mucosa [4], proving successful for urethral reconstruc-
tion. However, in many cases, an adequate amount of
donor tissue is not available [5]. In addition, substantial
donor site morbidity, including submucosal scarring,
pain, numbness, injury to salivary ducts, and limitation
of mandibular movement, has been reported [6].
Furthermore, complications, such as fistulae, hair
growth, graft shrinkage, strictures, stone formation,
and diverticulum, occur in the long term following
the procedure [7].
The use of tissue-engineered grafts to repair urethral
defects is considered to be an approach with therapeutic
potential. Natural collagen materials, such as bladder
submucosa (BSM) [8, 9], small intestinal submucosa
(SIS) [10], or collagen type I matrix [11], have already
been successfully used in urological tissue engineering
for short urethral defects both experimentally [12] and
clinically [13]. Previous studies [8, 14] demonstrated
that a SIS decellularization procedure including a 5%
peracetic acid (PAA) treatment step leads to higher
porosity and larger pore size. These porous microstruc-
tures allow cell infiltration into the matrix and have
fewer heterogeneous cellular proteins, thereby prevent-
ing complications, such as inflammatory reactions, fi-
brosis, calcification, and graft shrinkage.
Another critical element required for successful ur-
ethral tissue engineering is the cell source. A subpop-
ulation of stem cells can be easily isolated from
human voided urine [15–17], i.e., urine-derived stem
cells (USCs). USCs are multipotent cells that have
been widely demonstrated to terminally differentiate
into a variety of different cell types, including smooth
muscle cells (SMCs) and uroepithelial, endothelial,
osteogenic, adipogenic, chondrogenic, and neural
lineages [18]. Furthermore, autologous USCs can be
harvested using a simple, safe, low-cost, and non-
invasive procedure. Thus, USCs may be an excellent
alternative cell source for urological tissue engineer-
ing applications.
Therefore, we cultured autologous rabbit USCs be-
fore surgery and seeded them onto a 5% PAA-treated
SIS scaffold to reconstruct the urethra in rabbits. This
cell-based tissue-engineered urethra may be useful to




Fresh porcine small intestines were obtained and chem-
ically modified according to a protocol published previ-
ously by Liu et al. [9]. The mucosa and serosa were
mechanically removed and washed in distilled water. For
decellularization, SIS samples were treated with 5% PAA
for 4 h with agitation on an orbital shaker at 200 rpm at
4 °C. After decellularization, they were treated with 1%
Triton X-100 for a further 2 days. Then, the SIS was
washed in distilled water for another 72 h. Finally, the
SIS scaffold was sterilized using 0.1% PAA prepared in
20% ethanol for 2 h, rinsed six times with sterile phos-
phate buffer solution for 20 min each time, and stored
in sterile phosphate buffer solution containing 100 U/ml
penicillin and 0.1 mg/ml streptomycin at 4 °C until
needed.
Scanning electron microscopy
Fresh SIS and 5% PAA-treated SIS were fixed in 2.5% glu-
taraldehyde. The SIS samples were frozen at –80 °C for
24 h, sputter-coated with gold, and mounted for analysis.
Electron micrographs of mucosa slides were obtained
with an acceleration voltage of 25.0 kV at a magnifi-
cation of 400× using a Hitachi S-3000 N Scanning
Electron Microscope (Hitachi Technologies America,
Pleasanton, CA, USA).
DNA content
For measurement of residual DNA, fresh SIS and 5%
PAA-treated SIS samples were dabbed dry with tissue
paper and weighed. Samples were minced, and any
remaining nucleic acids were extracted using a com-
mercially available kit (DNeasy™, Qiagen, Valencia, CA,
USA). The DNA concentration in each sample was
calculated using a UV spectrophotometer (ND-2000,
NanoDrop Technologies, Wilmington, DE, USA) to
measure the absorbance at 260 nm. The DNA yield was
normalized to the initial wet weight of the samples.
Isolation of autologous rabbit USCs
Urine and bladder irrigation solution samples (average
total volume of approximately 60 ml/sample) were col-
lected from every rabbit that was to undergo surgery.
Each sample was centrifuged at 500 g for 5 min to col-
lect the cells, and the supernatant was carefully dis-
carded. The pelleted cells were gently resuspended in
medium (a 1:1 mixture of KSFM and embryonic fibro-
blast medium (EFM)) and plated in 24-well plates for
single-cell cultures. The medium was changed every
2 days after the initial 72 h, and cells were passaged at
70–80% confluency [15].
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Urothelial and smooth muscle differentiation of USCs
For urothelial differentiation, USCs were plated at a
density of 3000 cells/cm2 in medium composed of equal
amounts of KSFM and EFM containing 2% serum and
30 ng/ml epidermal growth factor (R&D Systems,
Minneapolis, MN, USA) and cultured for 14 days [19].
The medium was replaced every 3 days, and, on day 14,
the cells were analyzed by immunofluorescence (IF)
staining and Western blotting for urothelial cell (UC)-
specific markers (AE1/AE3).
For SMC differentiation, USCs were plated at a density
of 2000 cells/cm2 in myogenic differentiation medium
composed of equal amounts of DMEM and EFM contain-
ing 10% fetal bovine serum (FBS) as well as 2.5 ng/ml
transforming growth factor (TGF)-1 and 5 ng/ml platelet-
derived growth factor (PDGF)-BB (R&D systems) [18].
The medium was replaced every 3 days, and, on day 14,
the cells were analyzed by IF staining and Western blot-
ting for the SMC-specific marker myosin.
Autologous USC-seeded SIS scaffold preparation and
proliferation assay
A suspension of USCs was seeded on the serosal side of
the SIS at a density of 2 × 105 cells/cm2. On the third
day, the scaffolds were inverted and a similar number of
USCs was seeded onto the mucosal side of the SIS. Every
3 days, the scaffolds were inverted. After 14 days of cul-
ture, the USC-seeded, 5% PAA-treated SIS scaffolds were
ready to use for the experiment.
To analyze the cytotoxicity of the 5% PAA-treated SIS
scaffold, CCK-8 assays were performed. USCs cultured
in 96-well plates with 5% PAA-treated SIS were com-
pared with USCs cultured in 96-well plates without 5%
PAA-treated SIS. Briefly, 1000 USCs were seeded in each
well of 96-well plates. After the cells adhered, the
medium was removed, and medium containing 5% PAA-
treated SIS was added. Cells cultured without scaffolds
were used as the control.
Cell labeling and tracking
To detect differentiation of the seeded USCs, USCs were
labeled with a PKH67 green fluorescent labeling kit (Sigma
Aldrich) following the manufacturer’s protocol. Briefly,
USCs were incubated with PKH67 for 5 min and washed
four times to remove excess dye. After being labeled, the
cells were seeded into SIS scaffolds and transplanted into
rabbit urethras. IF was performed 2, 3, and 4 weeks after
transplantation for markers of the urothelium (AE1/AE3;
Abcam) and smooth muscle (myosin; Abcam).
Rabbit urethra reconstruction utilizing the SIS scaffold
All pre- and post-animal procedures were performed in
accordance with guidelines set forth by the Ethics
Committee of Chongqing Medical University, and
were approved by this committee (license number:
SCXK[YU]20110016). Twenty-four New Zealand white
male rabbits (2.0–2.5 kg) were randomly divided into
two groups, each containing 12 animals. Autologous
USCs had been obtained from each of these rabbits
and cultured. The experimental group received ure-
throplasty with an autologous USC-seeded 5% PAA-
treated SIS scaffold, and the control group received
urethroplasty with a 5% PAA-treated SIS scaffold
alone. Animals were anesthetized with pentobarbital
(30 mg/kg) administered intravenously and lidocaine
(6 mg/kg) administered subcutaneously to decrease
any pain during and after the surgery. A ventral ureth-
ral gap was created a mean of 2 cm from the external
urethral orifice, and the urethral mucosa was exposed
and completely removed, with a mean penile urethra
length of 2 cm. The urethral mucosal defect was
repaired with a SIS scaffold (control group: 5% PAA-
treated SIS alone with no USCs; experimental group:
autologous USC-seeded 5% PAA-treated SIS; n = 12
for each group). The SIS scaffold ends were anasto-
mosed with the native ends of the urethral tissue using
6-0 absorbable sutures in a water-tight fashion. The
wound was closed in layers in a routine fashion. An
8 F silicone catheter was indwelled and fastened with
6-0 absorbable sutures to provide bladder drainage for
the 14 days following the operation. Each group was
sacrificed at the 2, 3, 4, or 12 week time point. At
12 weeks, the animals in the two groups were assessed
with retrograde urethrograms.
Histological analysis
Fresh SIS, 5% PAA-treated SIS, USC-seeded 5% PAA-
treated SIS, and urethral specimens were fixed in 10%
buffered formalin, embedded in paraffin, and proc-
essed for histology (hematoxylin and eosin (H&E)
staining, 4′,6-diamidino-2-phenylindole (DAPI) stain-
ing, Masson’s trichrome staining, immunohistochem-
istry (IHC), and IF). IHC was performed using
monoclonal antibodies against the urothelium (AE1/
AE3; Abcam), smooth muscle (myosin; Abcam), and
vascular endothelium (CD31; Abcam). Briefly, con-
secutive 4.0-μm sections were prepared using a cryo-
stat and incubated overnight at 4 °C with the following
primary antibodies: anti-AE1/AE3 diluted 1:75, anti-
myosin diluted 1:100, and anti-CD31 diluted 1:150.
Then, sections were washed with phosphate-buffered
saline (PBS) and incubated with the appropriate sec-
ondary antibody diluted 1:200 for 60 min at room
temperature. Finally, the slides were rinsed twice with
PBS and counterstained with hematoxylin or DAPI. IF
was performed using monoclonal antibodies against
the urothelium (AE1/AE3; Abcam) and smooth
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muscle (myosin; Abcam). Briefly, frozen sections
(6.0 μm) or cells were fixed in 4% paraformaldehyde
and blocked with 5% bovine serum albumin. Subse-
quently, the sections were treated overnight at 4 °C
with the following primary antibodies: anti-AE1/AE3
diluted 1:75 or anti-myosin diluted 1:100. They were
then incubated with a secondary antibody (IgG labeled
with fluorescein) and counterstained with DAPI.
Statistical analysis
The data are presented as mean and standard error of
the mean for each group. Individual comparisons were
made between groups using two-tailed Student’s t tests.
Differences were considered statistically significant for P
values < 0.05.
Results
Histological analysis of the SIS
Examination of fresh SIS stained with H&E, Masson’s
trichrome, and DAPI (Fig. 1) showed that, without 5%
PAA, some nuclear material remained in the SIS. By
contrast, after treatment with 5% PAA, the nuclear ma-
terial was almost completely removed and the tissue
structure became visibly more porous.
Scanning electron microscopy
Scanning electron micrographs (Fig. 2a, b, c, and d)
showed dense ultrastructure on the mucosal and
serosal sides of fresh SIS. By contrast, after treatment
with 5% PAA, porosity was visible on the surface. The
diameter of these pores ranged from 50 to 150 nm,
greater than the average cell diameter, which allowed
homogenous cell infiltration into the three dimensional
(3D) scaffold [9].
DNA content and proliferation assay
The DNA content analysis (Fig. 2e) showed a decrease
in DNA content after 5% PAA treatment. The difference
in DNA content between the two groups was significant
(P < 0.05). The USCs grew well in medium containing
the 5% PAA-treated SIS scaffold, and the OD (optical
density) values in the scaffold groups were similar to
those in the control group (P > 0.05) (Fig. 2f ).
Characteristics and multipotent differentiation of USCs
Single USCs were observed 3–4 days after initial seeding
(Fig. 3Aa). These cells then formed clones within the
next 4–7 days (Fig. 3Ab, c), and single USCs were able
to expand into a large population (Fig. 3Ad). They ex-
hibited a characteristic “rice grain”-like morphology
(Fig. 3Ad). After several passages, the cells retained their
“rice grain” morphology. USCs that differentiated into
smooth muscle showed a spindle-like morphology
(Fig. 3Bb) and expressed the skeletal muscle-specific
protein myosin (Fig. 3Cc).Cells that differentiated into
urothelium exhibited a cobblestone-like morphology
Fig. 1 Histological analysis of the SIS. H&E (a and d), Masson’s trichrome (b and e), and DAPI staining (c and f) of cross-sections of fresh SIS (a, b,
and c) and 5% PAA-treated SIS (d, e, and f). Nuclear material was found in fresh SIS tissue (arrows; a, b, and c). However, treatment with 5% PAA
completely removed the nuclear material (d, e, and f). Scale bar = 200 μm. DAPI 4′,6-diamidino-2-phenylindole, H&E hematoxylin and eosin, PAA
peracetic acid, SIS small intestinal submucosa
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(Fig. 3Bc) and expressed the urothelium-specific proteins
AE1/AE3 (Fig. 3Cf ). Western blot analysis revealed that
myosin and AE1/AE3 (Fig. 3D) were present in induced
urine-derived cells.
Seeding of autologous USCs onto SIS scaffolds
Macroscopy showed that collagen-based scaffolds de-
rived from porcine SIS had been mechanical and chem-
ically treated to remove cells (Fig. 4a). Examination of
the H&E and DAPI (Fig. 4b and c) staining showed that
there were two to four layers of USCs attached to both
sides of the 5% PAA-treated SIS scaffold after seeding.
Macroscopy and retrograde urethrogram evaluation
All animals in both groups survived the duration of the
study with no abnormal findings. At 3 months, macro-
scopy and a retrograde urethrogram of the urethra
(Fig. 5) showed evidence of strictures. All of the animals
treated with 5% PAA-treated SIS alone exhibited stric-
tures, and only one animal in the autologous USC-
seeded 5% PAA-treated SIS group exhibited minor
strictures.
Cell labeling and tracking
IF staining was used to detect differentiation of the
seeded USCs. After labeling, USCs exhibited green
fluorescence (Fig. 6a). PKH67-positive USCs were
found beneath the luminal surface of the urethra, and
some PKH67-positive USCs expressed AE1/AE3 and
myosin (Fig. 6b).
Histopathological evaluation of retrieved urethras
H&E and AE1/AE3 IHC staining (Fig. 7a and b) was
used to assess urothelial regeneration. In the group
treated with 5% PAA-treated SIS only, a discontinuous
epidermal layer was observed on the luminal surface of
the urethra 2 weeks after surgery, and the cellular layer
continued to increase over time. At 3 months, the lu-
minal surface had formed an intact and multilayered
urothelium. However, infiltration of inflammatory cells
and fibrocytes (Fig. 7c) was observed, indicating an in-
flammatory reaction and fibrosis. By contrast, complete
epidermal cellular layers were formed at 2 weeks in the
group treated with autologous USC-seeded 5% PAA-
treated SIS, and the urothelium continued to increase
over 3 months but then did not change after 3 months.
At 2, 3, and 4 weeks postoperatively, the amount of
urothelium was significantly different between the two
groups (P < 0.05) by histomorphometric analysis
(Fig. 7d).
Masson’s trichrome and myosin IHC staining (Fig. 8a
and b) was used to assess smooth muscle regeneration. In
the group treated with 5% PAA-treated SIS only, positive
expression of myosin beneath the urothelium was ob-
served 3 weeks after the surgery, and the smooth muscle
content continued to increase over time. By contrast, ex-
pression was seen at 2 weeks in the group treated with au-
tologous USC-seeded SIS. In addition, the smooth
muscle-to-collagen ratio, assessed by Masson trichrome
staining, and the smooth muscle-to-total area ratio,
assessed by myosin IHC staining, were significantly
Fig. 2 Scanning electron microscopy, DNA content analysis, and proliferation assay. Electron micrographs of the mucosal (b and d) and serosal
(a and c) sides of fresh SIS (a and b) and 5% PAA-treated SIS (c and d). A high level of porosity and large pore size were evident after treatment
with 5% PAA. Scale bar = 60 μm. The DNA content analysis (e) showed a decrease in DNA content after treatment with 5% PAA. A significant
difference in the DNA content was observed between the two groups (*P < 0.05). f Analysis of cell growth. The OD values in the scaffold groups
were similar to those in the control group (P > 0.05). d days, OD optical density, PAA peracetic acid, SIS small intestinal submucosa
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higher in the autologous USC-seeded 5% PAA-treated
group than in the 5% PAA-treated SIS alone group (P
< 0.05) at 3 and 4 weeks and 3 months (Fig. 8c and d).
Furthermore, the smooth muscle became more orga-
nized and stained more intensely in the autologous
USC-seeded 5% PAA-treated SIS group. Western blot
analysis showed that the smooth muscle contents in
the two groups were significantly different (Fig. 8e).
Evidence of vascularization assessed using CD31
(Fig. 9a) was also detected in the two groups. The
Fig. 3 Characteristics and multipotent differentiation of USCs. a Single USCs can be expanded to a large population. Single cells appeared on day
4 (aa), clone formation was observed on day 6 and 7 (abc), and cell confluency was achieved on day 11 (ad). Scale bar = 100 μm. b USCs
(passage 2) were induced to differentiate into two distinct lineages. The morphology of USCs (ba) is shown after induction with SMC induction
media (bc) and UC induction media (bb) for 14 days. Scale bar= 100 μm. c IF staining of myogenic-induced (ca–cc) and urothelial-induced (cd–cf) USCs.
Specific marker staining (red) and nuclear staining by DAPI (blue) are shown. Scale bar= 50 μm. d Detection of the SMC-specific marker (myosin; da) and
UC-specific markers (AE1/AE3; db) by Western blotting. Specific bands are seen in lanes with proteins from induced USCs and the positive control. DAPI
4′,6-diamidino-2-phenylindole, SMC smooth muscle cell, UC urothelial cell, USC urine-derived stem cell
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Fig. 4 Seeding of SIS scaffolds with autologous USCs. a Collagen-based scaffolds derived from porcine SIS were mechanically and chemically
treated to remove cells. H&E (b) and DAPI (c) staining showed that there were two to four layers of USCs attached to both sides of the 5%
PAA-treated SIS scaffold after seeding. Scale bar = 200 μm
Fig. 5 Macroscopy and retrograde urethrograms of retrieved urethras. a A normal urethra, b a wide urethra in the autologous USC-seeded SIS
group, and c urethral strictures in the group that received treated SIS alone (arrow)
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number of vessels significantly differed between the two
groups at 2 and 3 weeks (P < 0.05), but the diameter of
the vessels was not significantly different by histomor-
phometric analysis (Fig. 9b).
Discussion
Many donor tissues have been used for urethral recon-
struction, including free skin grafts, bladder mucosa, co-
lonic mucosa, buccal mucosa, and lingual mucosa;
however, these are not satisfactory and often lead to
complications, such as anastomotic strictures and fis-
tulas [20–22]. Furthermore, the use of these tissues re-
quires the harvesting of tissue from a secondary site, and
donor site morbidity has been reported [2, 6, 23–26].
Tissue engineering technology provides an alternative
approach to build a functional urethra for patients who
require urethral reconstruction. Various biodegradable
scaffolds have been introduced for urethral reconstruc-
tion, including natural collagen materials [8–11] and
synthetic polymers such as poly(glycolic acid) [27] and
poly(lactic-co-glycolic acid) [28]. However, synthetic bio-
materials limit the biologically active molecules that
allow tissue regeneration across the graft to proceed,
and quickly restrict its application [14]. Natural collagen
materials are derived from natural tissues. Their cellular
components are removed by a combination of mechan-
ical and chemical manipulation, and extracellular matrix
components, such as collagen, fibronectin, laminin, gly-
cosaminoglycans, and growth factors, are retained. They
have already been successfully used in urological tissue
engineering to treat short urethral defects, both experi-
mentally [12] and clinically [13], with materials such as
BSM [8, 9], SIS [10], and collagen type I matrix [11].
However, natural collagen materials also have certain
disadvantages that limit their clinical application. After
conventional decellularization procedures, SIS often
does not possess the highly interconnected macroporous
or microporous structures that allow cell infiltration into
the matrix, and the material retains some heterogeneous
cellular proteins. Despite the high density of collagen
and residual heterogeneous cellular proteins, the mater-
ial can block host cells or seeded cells from infiltrating
the collagen matrix and lead to complications. In this
study, we combined manual agitation (physical) and Tri-
ton X-100 treatment with high concentrations of PAA
(chemical) for decellularization of SIS. Similar combina-
tions have been successfully used in previous studies [9,
14, 29]. After treatment with 5% PAA, the porosity and
pore size, ranging from 10 to 150 nm on the surface, are
higher and larger than SIS without PAA treatment,
which allows host cells to infiltrate the SIS scaffold [8]
and enhances the transport of nutrients and metabolic
waste products [30, 31]. In addition, they are almost
completely free of heterogeneous cellular compounds,
which could lead to immune reactions, strictures, and fi-
brosis [29]. Furthermore, the proliferation assay revealed
that 5% PAA-treated SIS scaffolds were biocompatible
with the USCs. Thus, treatment with 5% PAA contrib-
utes to better tissue regeneration.
In addition, the use of acellular matrix is only indi-
cated for short strictures when a healthy and well-
vascularized part of the urethral wall exists, with a limit
of <1.0 cm for tissue regeneration [32]. Many previous
studies [5, 10, 33] have shown that, in urethral
Fig. 6 Cell labeling and tracking. USCs were labeled with PKH67 in vitro (a) and their differentiation after transplantation was assessed (b).
Engrafted USCs were positive (arrows) for urothelial (AE1/AE3) and smooth muscle (myosin) markers. DAPI 4′,6-diamidino-2-phenylindole, w weeks
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Fig. 7 (See legend on next page.)
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reconstruction, cell seeding is necessary to decrease
complications when matrices are used. Two types of
cells have been introduced for urethral reconstruction.
First, adult cells, such as UCs [5, 34, 35], epidermal cells
[36], SMCs [37], lingual keratinocytes [37, 38], mesothe-
lial cells [39], and fibroblasts [38], have often been used.
However, culturing of these cells has a low success rate,
and they also have a limited expansion capability in cul-
ture. Second, stem cells, including mesenchymal stem
cells [40] and adipose-derived stem cells [27], have been
used for tissue engineering. However, these cells have
certain disadvantages that limit their clinical application,
such as a low differentiation capacity (<5% yield of UCs
of endodermal lineage), a short lifespan in vitro (<10
passages for bone marrow stem cells), and the need for
invasive collection procedures [16]. In this experiment,
we were able to harvest autologous USCs and expand
them to sufficient numbers for scaffold seeding using a
simple, safe, low-cost, and non-invasive procedure. USCs
possess both self-renewal and multilineage differenti-
ation capabilities; they can differentiate into osteocytes,
chondrocytes, adipocytes, skeletal myocytes, interstitial
cells, and endothelial cells [15, 18]. We demonstrated
that USCs were able to differentiate into cells of the
smooth muscle lineage (mesodermal origin) and urothe-
lial lineage (endodermal origin) in vitro; therefore, USCs
may assume the role of urethral SMCs and UCs. Because
the cells were to be grafted into recipients, immuno-
logical rejection should be considered. However, autolo-
gous cells have no issues relevant to immunological
rejection. In addition, as a type of stem cell, USCs also
can regulate the immune response by inhibiting inflam-
matory and immunomodulatory factors.
Previous studies [14, 41] have shown that a 3D porous
biological collagen matrix provides favorable conditions
for USC expansion and differentiation, and that USC-
seeded 3D porous biological collagen matrix can be used
to construct a tissue-engineered urethra. It is not clear
whether USC-seeded 3D porous biological collagen
matrices are an effective therapy in vitro. Data from pre-
vious studies [9, 14, 41] were used as a foundation to ex-
tend the use of autologous USCs seeded on a 3D porous
SIS to construct a tissue-engineered urethra. In this
study, we investigated the feasibility and availability of
an autologous USC-seeded 3D-porous SIS scaffold to re-
construct the urethra.
In this study, H&E and DAPI staining revealed that
autologous USCs were successfully seeded into 3D por-
ous SIS scaffolds on both sides, and the cells attached
well and formed a multilayer of cells on the surface of
the SIS. Additionally, H&E and AE1/AE3 IHC staining
showed integrated epidermal cell layers in the autolo-
gous USC-seeded 3D porous SIS scaffold group 2 weeks
after the operation. By comparison, stratified epidermal
cellular layers were formed at 3 weeks. Despite the infil-
tration of the host epithelial cells, there was no signifi-
cant difference in urothelial regeneration between the
two groups at 3 months. However, the early integrated
epidermal cellular layers attached to the luminal surface
of the urethra may provide a permeability barrier that
can prevent urine leakage from the underlying tissues,
which is one of the major factors implicated in the in-
flammatory infiltration and fibrous tissue deposition that
lead to stricture formation. Importantly, Masson’s tri-
chrome, myosin IHC staining, and functional analysis
showed that the animals that received the autologous
USC-seeded 3D porous SIS scaffold showed improve-
ment over those that received the 3D porous SIS scaffold
alone. SMCs were seen in the autologous USC-seeded
3D porous SIS scaffold group 2 weeks postoperatively.
These continued to develop and approximate normal tis-
sues throughout the study with no abnormal findings.
By comparison, SMCs began to appear at 3 weeks post-
operatively. The smooth muscle-to-collagen ratio and
the content of smooth muscle were significantly
higher in the autologous USC-seeded 3D porous SIS
group than in the 3D porous SIS alone group (P <
0.05) at 3 and 4 weeks and 3 months. Additionally, all
of the animals in the 3D porous SIS alone group
exhibited strictures, and only one animal in the au-
tologous USC-seeded 3D porous SIS group exhibited
minor strictures. The number of vessels was signifi-
cantly higher in the autologous USC-seeded 3D por-
ous SIS group than in the 3D porous SIS alone group
at early time points, which allowed host cells to infil-
trate the scaffold and enhanced the transport of nutri-
ents and metabolic waste products, thereby promoting
urethral regeneration. We also demonstrated that the
(See figure on previous page.)
Fig. 7 Histopathological evaluation of urothelium regeneration. H&E (a) and AE1/AE3 IHC (b) staining was used to assess the urothelial regeneration at
2, 3, and 4 weeks and 3 months after transplantation. In the 5% PAA-treated SIS only group, a discontinuous epidermal layer was observed on
the luminal surface of the urethra 2 weeks after surgery, and the cellular layer increased over time. At 3 months, the luminal surface had
formed an intact and multilayered urothelium. By contrast, complete epidermal cellular layers were formed at 2 weeks in the autologous USC-seeded
5% PAA-treated SIS group, and the urothelium continued to increase over 3 months but then did not change after 3 months. c Infiltration of
inflammatory cells (arrow) and fibrosis (*) were observed in the 5% PAA-treated SIS only group. Scale bar = 200 μm. d Image analysis was used
to calculate the ratio of the AE1/AE3-positive area to the total area at each time point in the two groups. *Significantly lower than in the autologous
USC-seeded 5% PAA-treated SIS group at 2, 3, and 4 weeks after transplantation (P < 0.05). m months, USC urine-derived stem cell, w weeks
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native urethra environment in the animal appeared to
provide enough stimuli to cause the USCs to differenti-
ate into SMCs and UCs and to assume the role of ur-
ethra SMCs and UCs. In addition, USCs secrete a
variety of growth factors, such as vascular endothelial
growth factor (VEGF), PDGF, PLGF, basic fibroblast
growth factor, epidermal growth factor, and TGF-β
[42]. VEGF expression enhances muscle regeneration in
vivo [43]. This might lead to the recruitment of host
cells, a direct effect of angiogenesis, and contribute to
the smooth muscle and urothelial layers that repopulate
the urethra. These findings indicate that autologous
USCs can promote urothelium and smooth muscle re-
generation and vessel infiltration and decrease the in-
dwelling time, thus reducing complications, such as
infection, scarring, and strictures.
In this study, however, inflammatory cell infiltration
and fibrosis were found in the SIS alone group. In
addition, all animals in the SIS alone group exhibited
strictures, and one animal in the autologous USC-seeded
(See figure on previous page.)
Fig. 8 Histopathological evaluation of smooth muscle regeneration. a,b Smooth muscle regeneration. Representative Masson’s trichrome (a) and
myosin IHC (b) staining in retrieved urethras 2, 3, and 4 weeks and 3 months after transplantation. In the 5% PAA-treated SIS only group, positive
expression of myosin beneath the urothelium was observed 3 weeks after the surgery, and the smooth muscle content continued to increase
over time. By contrast, expression appeared at 2 weeks in the autologous USC-seeded SIS group. Scale bar = 200 μm. c,d Image analysis. The
smooth muscle-to-collagen ratio (c) assessed using Masson’s trichrome staining and the smooth muscle-to-total area ratio (d) assessed using
myosin IHC staining at 3 and 4 weeks and 3 months in the two groups. These parameters were significantly higher in the autologous USC-seeded
5% PAA-treated SIS group than in the 5% PAA-treated SIS only group (*P < 0.05) at 3 and 4 weeks and 3 months. e Detection of SMC-specific markers
(myosin) by Western blotting. m months, USC urine-derived stem cell, w weeks
Fig. 9 Histopathological evaluation of vascularization. a CD31 IHC staining was used to assess vascularization at 2, 3, and 4 weeks and 3 months
after transplantation. Scale bar = 200 μm. b Image analysis was used to quantify the number and diameter of vessels in the two groups at each
time point. The number of vessels significantly differed between the two groups at 2 and 3 weeks (*P < 0.05), but the diameter of the vessels was
not significantly different. m months, USC urine-derived stem cell, w weeks
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group exhibited minor strictures. Due to the immuno-
modulatory and immunosuppressive properties of USCs,
it is believed that they can secrete immunomodulatory
factors after transplantation, including interleukins (ILs;
such as IL-2 and IL-12), cytokines (such as interferon
and granulocyte colony-stimulating factor), and chemo-
kines (such as macrophage inflammatory protein-1α)
[42], and inhibit peripheral blood mononuclear cell (T
and B cell) proliferation [44]. Moreover, in control ani-
mals, in which USCs were not seeded on the scaffolds,
immunoreaction was one of the major factors implicated
in the inflammatory cell infiltration that led to stricture
formation. Another contributing factor to the success of
urethral reconstruction could be the permeability barrier
formed by the USCs. For these reasons, histological ana-
lysis and the retrograde urethrogram did not show an
immune reaction, an inflammatory response, or stricture
formation within the autologous USC-seeded 3D porous
SIS scaffold group.
Although this study provides evidence that autolo-
gous USC-seeded 3D porous SIS scaffolds can be used
to construct a tissue-engineered urethra, it has some
limitations. First, we did not analyze the bioactive fac-
tors, such as growth factors and cytokines, that are se-
creted by USCs and which are believed to enhance
tissue regeneration. Second, in the present study, the
urethral defect models were established in normal ani-
mals, which cannot fully simulate the exact clinical
situation of urethral strictures, which is characterized
by a fibrotic urethral bed. Finally, the number of experi-
mental animals that were evaluated per time point is
small. Further investigations are necessary to translate
this technology into the clinic.
Conclusions
USCs that can be easily isolated from voided urine can
be extensively expanded to high numbers in vitro, and
efficiently give rise to UCs and SMCs in vitro and vivo.
They can be utilized as a promising cell source for
tissue-engineered urethras. In addition, 3D porous SIS
as an optimized biomaterial has potential as a cell-based
scaffold for tissue-engineered urethra. Furthermore, an
autologous USC-seeded 3D porous SIS scaffold could
promote urethral regeneration.
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